FT Health Discusses Findings From World Malaria Report, Features Interview With DNDi Executive Director

FT Health: Progress stalls in fight against malaria
The latest issue of the Financial Times’ weekly global health newsletter highlights findings from the World Malaria Report and features an interview with Bernard Pécoul, executive director of the Drugs for Neglected Diseases Initiative (DNDi), who discusses the recent E.U. regulatory approval of the initiative’s drug, fexinidazole, to treat sleeping sickness. The newsletter also provides a round-up of global health-related news stories (Jack/Dodd, 11/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.